Emerging Treatments for Vulvar Lichen Sclerosus Offer Promising ...
Mar 11, 2020 · Insights to current and emerging treatment strategies for vulvar lichen sclerosus (LS), a chronic and inflammatory skin disorder associated with risk for vulva scarring and sexual dysfunction, were offered in a review paper published in the International Journal of Women’s Health.. The estimated prevalence of LS is currently unknown, but it is suggested that approximately 1 in 70 women who ...
Isotretinoin Generic Available Again for Severe Acne
Jun 3, 2019 · Zenatane is a generic version of Accutane, a drug for nodular acne unresponsive to antibiotics. It requires a special program (iPLEDGE) to prescribe and dispense, and is available in 10mg to 40mg capsules.
Green Nail Syndrome (GNS, Pseudomonas nail infection, …
Mar 13, 2019 · Green nail syndrome is a bacterial infection of the nail caused by Pseudomonas aeruginosa. It results in greenish or greenish-black discoloration of the nail, chronic paronychia, and onycholysis. Learn about the risk factors, differential diagnosis, and treatment options.
Topical for Seborrheic Keratoses May Be Effective Alternative to ...
Sep 7, 2021 · A topical cosmetic cream with urea and hydroxy acids shows efficacy and tolerability in the treatment of patients with seborrheic keratoses, according to a study published in the Journal of Cosmetic Dermatology. The cream reduces the number and thickness of seborrheic keratoses, improves quality of life, and has no adverse events.
Can Seasonal Allergies Cause Rash? - Dermatology Advisor
Feb 9, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Seasonal allergies, also known as hay fever or seasonal allergic rhinitis, are most commonly triggered by plant pollen, grass, mold, and ragweed. 1 The abundance of these triggers varies throughout allergy season, which occurs in …
Alopecia Areata: Baricitinib and Ritlecitinib Show Highest …
Feb 22, 2024 · The rank probability test for the mean change in SALT score indicates that baricitinib at a 4 mg dose exhibits the highest likelihood of being the most efficacious treatment. This was closely followed by ritlecitinib at a combined dose of 200 mg and 50 mg, ivarmacitinib at doses of 4 mg and subsequently 8 mg, ritlecitinib 50 mg, baricitinib 2 mg, ritlecitinib 30 mg, deuruxolitinib 12 mg ...
Laser-Assisted Treatment Effective for Actinic Keratosis
Mar 7, 2019 · For patients with high-grade actinic keratosis lesions, ablative fractional laser (AFL)-assisted photodynamic therapy (PDT) with the use of high laser depth parameters is recommended, according to the results of a single-blinded, randomized, comparative, prospective study (ClinicalTrials.gov identifier: NCT03325803).Findings from the analysis were published in the Journal of the American ...
Dermatology CME/CE Courses - Dermatology Advisor
myCME is the premier destination for continuing medical education (CME) and continuing education (CE), committed to providing high-quality, evidence-based, and user-friendly courses tailored to the needs of physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals across 20+ specialties.. Featured below are dermatology CME/CE courses ...
Rapamycin Cream Safe and Effective Treatment for Facial …
Aug 31, 2023 · A study found that topical rapamycin cream at 0.5% and 1% improved facial angiofibroma severity and appearance in patients with tuberous sclerosis complex (TSC). The cream was safe, well-tolerated, and had no systemic rapamycin absorption.
Updated Guidelines on Presentation, Diagnosis ... - Dermatology …
Nov 4, 2021 · Ocular manifestations of lichenoid dermatoses, such as lichen planus (LP), lichen planus pigmentosus (LPP), and lichen planopilaris (LPL), are rare and often overlooked by dermatologists, but lead to serious complications. An up-to-date review for dermatologists on ocular manifestations of LP, LPP and LPL, as well as guidelines on when to refer patients to the ophthalmologist, was published in ...